Shareholder Information

Overview

Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on proprietary genetic, epigenetic and other complex molecular technologies.

Mdxhealth is dedicated to providing highly accurate and clinically actionable urologic solutions to inform patient diagnosis and treatment while improving healthcare economics for payers and providers.

Mdxhealth is listed on the Euronext and on NASDAQ under the ticker symbol MDXH.

Mdxhealth has been listed on Euronext since 2006 and on NASDAQ since 2021. There is only one class of shares in the company (common shares) and all shares have the same rights and voting representation. Other than American Depository Shares (ADS) listed on NASDAQ (each representing ten common shares) and stock options issued to employees, directors, and some consultants, there are no other financial instruments issued by the company.

The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. Mdxhealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3

Major Shareholders

Mdxhealth’s shareholder structure, based on the most recent number of shares and transparency notifications and filings, is as follows:

The Articles of the Association of mdxhealth SA provide for shareholders notification threshold of 3%, 5% or a multiple of 5% (i.e. 10%, 15%, 20% etc) of the total number of existing voting rights. The notification forms can be downloaded from the website of the FSMA. Completed and signed forms should be sent to ir@mdxhealth.com. Please see transparency press releases and SEC filings for further details.
Edit

Convening Notice (EN) | Invitation (FR)

Attendance Form (EN) | Formulaire de Participation (FR)

Proxy Form (EN) | Formulaire de Procuration (FR)

Voting by mail Form (EN) | Formulaire de Vote par Correspondance (FR)

Outstanding Shares and Voting Rights (EN) | Actions et Droits de Votes en Circulation (FR)

Comptes Annuels Statutaires (non consolidés) (FR)

2021 Annual Report – Consolidated Financial Statements (EN) | Comptes Annuels Consolidés (FR)

Rapport Annuel du Conseil d’Administration sur les Comptes Annuels Statutaires (non consolidés) (FR)

Annual Report of the Board of Directors on the Consolidated Financial Statements (EN) | Rapport Annuel du Conseil d’Administration sur les Comptes Annuels Consolidés (FR)

Report of the Statutory Auditor on the (non-consolidated) Statutory Financial Statements (EN) | Rapport du Commissaire sur les Comptes Annuels Statutaires (non consolidés) (FR)

Report of the Statutory Auditor on the Consolidated Financial Statements (EN) | Rapport du Commissaire sur les Comptes Annuels Consolidés (FR)

Board Report in relation to the 2022 Share Option Plan (EN) | Rapport du Conseil d’Administration sur le Plan d’Option sur Action de 2022 (FR)

Rapport du Commissaire sur le Plan d’Option sur Action de 2022 (FR)

2022 Share Option Plan (EN) | Plan d’Option sur Action de 2022 (FR)

Edit

Minutes of the Ordinary General Meeting of the Shareholders May 25, 2022: English I Français

Minutes of the Special General Meeting of the Shareholders May 25, 2022: Français

Minutes of the Ordinary General Meeting of the Shareholders May 27, 2021: English I Français

Minutes of the Special General Meeting of the Shareholders May 27, 2021: Français

Minutes of the Special General Meeting of the Shareholders July 30, 2020: English I Français

Minutes of the Extraordinary General Meeting of the Shareholders July 30, 2020: Français

AGM Minutes – May 28 2020 – English (free translation)

AGM Minutes – May 28 2020 – Français

EGM Minutes – May 28 2020 – Français

AGM 2019 – minutes (French)

2018_05_31_AGSM_Minutes: Français

2017_05_26_AGSM_Minutes: Français

June 20, 2016 extraordinary general shareholder meeting minutes: Français

May 27, 2016 annual general shareholders meeting minutes: Français

May 27 2016 extraordinary general shareholder meeting non proceedings minutes: Français

May 29th, 2015 annual general shareholders’ meeting minutes: Français

June 23th, 2014 extraordinary general shareholder meeting minutes: Français

May 30th, 2014 : annual general shareholders’ meeting minutes: Français

May 30th, 2014 : extraordinary general shareholder meeting minutes: Français

June 27th, 2013, extraordinary general shareholder meeting minutes (with correction): Français

June 27th, 2013, extraordinary general shareholder meeting minutes (with error): Français

May 31, 2013, extraordinary general shareholder meeting non proceedings minutes: Français

May 31st, 2013 : annual general shareholders’ meeting minutes: Français

May 25, 2012, board report for extraordinary general shareholders’ meeting: English

May 25, 2012, board report for extraordinary general shareholders’ meeting: Français

May 25, 2012, extraordinary general shareholder meeting non-proceedings minutes: Français

May 25, 2012, annual general shareholders’ meeting minutes: Français

June 21, 2011, extraordinary general shareholder meeting minutes: Français

May 27, 2011, annual general shareholders’ meeting minutes: Français

February 18, 2011, extraordinary general shareholder meeting minutes: Français

February 18, 2011 board report for Extraordinary General Shareholders meeting: English

February 18, 2011 board report for extraordinary general shareholders meeting: Français

May 28, 2010, annual general shareholder meeting minutes: Français

April 6, 2010, extraordinary general shareholders meeting: English

April 6, 2010, extraordinary general shareholders meeting: Français

May 29, 2009, annual general shareholder meeting minutes: Français

May 30, 2008, extraordinary general shareholder meeting minutes: Français

May 30, 2008, annual general shareholder meeting minutes: Français

Investor Relations Contact

For all investor related questions please call or email:

LifeSci Advisor (PR & IR)

US: +1.949.271.9223
ir@mdxhealth.com